Document is current
Any future updates will be listed below
-
Authors
Roland, Noémie https://orcid.org/0000-0002-8079-4263
Sonne, Heidi
Pellesi, Lanfranco
Bramming, Maja
Cardél, Lise Gehrt
Pottegård, Anton
Kildegaard, Helene
-
Funding
Funding for this research was provided by:
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 4 June 2026
Accepted: 13 July 2026
First Online: 5 August 2026
Declarations
Ethics approval and consent to participate: According to Danish law, studies based solely on register data do not require approval from an ethics review board. All authors have given their consent for publication.
Competing interests: Anton Pottegård reports participation in regulator-mandated phase IV-studies funded by AbbVie, Alcon, Almirall, Astellas, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, LEO Pharma, Novo Nordisk, Pfizer, and Servier, and on sponsor-initiated research projects with Novo Nordisk, all with funds paid to the institution where he is employed (no personal fees). Maja Bramming and Lise Gehrt Cardél are employees of Novo Nordisk. The other authors have no conflicts of interest to declare.
